QuantumCyte

QuantumCyte is a private life science tools and molecular pathology company developing automated tissue microdissection and cellular enrichment solutions for precision diagnostics and biopharma research. Its flagship QCPRECISE platform connects digital pathology annotations with automated on-slide masking and lysis to isolate high-purity regions of interest from solid tissue biopsies for downstream genomics, transcriptomics, proteomics, and next-generation sequencing workflows. The company markets its technology to clinical and reference laboratories as well as pharmaceutical and translational research teams, with a focus on improving performance on low-tumor-content and otherwise challenging biopsy samples. QuantumCyte positions the platform as a way to reduce inconclusive results, improve variant detection sensitivity, accelerate biomarker discovery, and support targeted therapy development.